As Wall Street approaches the heigh of earnings season, CNBC’s Jim Cramer pinpointed the most important events happening next week — including the Federal Reserve’s meeting and earnings from Big Tech. Earnings are especially important as the government shutdown delays macro economic data, according to Cramer. He added that Friday’s gains make him fairly wary….
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Market update: Stocks are rallying on Friday, with the S & P 500 trading at a record high and extending its gains to roughly 2% this…
Shares of Eli Lilly and Novo Nordisk dropped Friday, after President Donald Trump said his administration aims to cut the cost of brand name GLP-1 weight loss drugs to $150 per month, a fraction of their current list price. “In London, you’d buy a certain drug for $130 and even less than that … $88…
The Amgen headquarters in Thousand Oaks, California. Eric Thayer | Bloomberg | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Drugmakers are increasingly using telehealth platforms to sell their medicines directly to patients…
Day three of the federal government shutdown came and went Friday, with no end in sight. The stock market saw more all-time highs before the rally ran out of steam. The S & P 500 on Friday eked out a fractional gain for its 29th record-high close since the market’s tariff lows in early April….
The Roche Holding AG headquarters on April 11, 2025, in Basel, Switzerland. Sedat Suna | Getty Images News | Getty Images Swiss pharmaceutical firm Roche is targeting becoming a top three obesity player globally, posing a potential rival to heavyweights Novo Nordisk and Eli Lilly as it advances one of its experimental weight-loss drugs to…
Jim Cramer and Jeff Marks, the Club’s director of portfolio analysis, on Thursday ran through all 31 portfolio holdings during the September Monthly Meeting. The two went over the best ways to play the stock market in the last months of 2025 while considering factors like the Federal Reserve’s monetary policy decisions, President Trump’s tariff…
Flags with the logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy are pictures while the company presents the annual report at Novo Nordisk in Bagsvaerd, Denmark, on February 5, 2025. Mads Claus Rasmussen | Afp | Getty Images Novo Nordisk said Wednesday that late-stage trial results…
Rafael Henrique | Lightrocket | Getty Images Britain’s GSK on Wednesday became the latest pharmaceutical firm to commit bumper investment into the U.S., as President Donald Trump is in the U.K. for a three-day state visit. The drug maker committed to investing at least $30 billion in U.S. research and developing (R&D) and manufacturing over…
Eli Lilly Biotechnology Center is shown in San Diego, California, March 1, 2023. Mike Blake | Reuters Eli Lilly on Tuesday said it will spend $5 billion to build a manufacturing facility in Goochland County, Virginia, to boost production capacity for targeted cancer drugs and other treatments — the first in a string of new…
